Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Operating Leases (2019 - 2025)

STRATA Skin Sciences' Operating Leases history spans 7 years, with the latest figure at $736000.0 for Q3 2025.

  • For Q3 2025, Operating Leases fell 26.55% year-over-year to $736000.0; the TTM value through Sep 2025 reached $736000.0, down 26.55%, while the annual FY2024 figure was $919000.0, 287.76% up from the prior year.
  • Operating Leases for Q3 2025 was $736000.0 at STRATA Skin Sciences, down from $780000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.2 million in Q1 2024 and bottomed at $237000.0 in Q4 2023.
  • The 5-year median for Operating Leases is $610000.0 (2022), against an average of $619789.5.
  • The largest annual shift saw Operating Leases crashed 61.15% in 2023 before it surged 287.76% in 2024.
  • A 5-year view of Operating Leases shows it stood at $392000.0 in 2021, then soared by 55.61% to $610000.0 in 2022, then plummeted by 61.15% to $237000.0 in 2023, then soared by 287.76% to $919000.0 in 2024, then decreased by 19.91% to $736000.0 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Operating Leases are $736000.0 (Q3 2025), $780000.0 (Q2 2025), and $835000.0 (Q1 2025).